ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $497,245 | +66.2% | 66,211 | 0.0% | 0.02% | +72.7% |
| Q1 2023 | $299,274 | -59.9% | 66,211 | 0.0% | 0.01% | -60.7% |
| Q4 2022 | $746,198 | +17.7% | 66,211 | 0.0% | 0.03% | +7.7% |
| Q3 2022 | $634,000 | +18.3% | 66,211 | 0.0% | 0.03% | +23.8% |
| Q2 2022 | $536,000 | -52.1% | 66,211 | 0.0% | 0.02% | -46.2% |
| Q1 2022 | $1,119,000 | -21.4% | 66,211 | 0.0% | 0.04% | -15.2% |
| Q4 2021 | $1,423,000 | +171.6% | 66,211 | +832.7% | 0.05% | +170.6% |
| Q3 2021 | $524,000 | – | 7,099 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |